Renal transplantation delays major adverse cardiac events (MACEs) in patients with end-stage renal disease: A nationwide population-based study

Hsien Tzung Liao, Ming Chin Lin, Chang Youh Tsai, Chien Yeh Hsu, Tsai Hung Wu

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Whether renal transplantation (RT) influences the risk of cardiovascular events remains controversial. Methods: This nationwide population-based study investigated the risk of major adverse cardiac events (MACEs) and stroke after RT in patients with end-stage renal disease (ESRD), using data obtained from the National Health Insurance Research Database in Taiwan. A total of 164 ESRD patients who underwent RT formed the study cohort, and an age- and sex-matched control group comprised 164 patients without RT selected from 6976 ESRD patients. All patients were enrolled between January 1, 2000 and December 31, 2009. Those who developed MACEs and/or stroke during the study period were identified according to the International Classification of Diseases, Ninth Revision, Clinical Modification. A Kaplan–Meier MACEs-free curve was used to compare MACEs episodes between the study and control groups. Results: The mean age was similar between RT and non-RT patients, with most between 30 and 50 years old. In this age range, MACEs developed in 47.5% of the RT group and in 52.5% of the non-RT group (p = 0.0882). The survival rate among all ESRD patients was significant higher in the RT group than in non-RT group (p < 0.001). The MACEs-free, stroke-free and MACEs-or-stroke-free rates were significantly higher in the RT group than in the non-RT group (p = 0.0134, 0.035 and 0.005, respectively) as demonstrated by Kaplan–Meier curves. Conclusion: RT seemed not to reduce the risk of MACEs directly, but it could have dramatically delayed MACEs and stroke episodes in the ESRD patients. Furthermore, a lower mortality rate was observed in the ESRD patients who received RT than in those undergoing chronic dialysis. Further in-depth investigation is necessary to identify other protective factors against MACEs or stroke in ESRD.

Original languageEnglish
Pages (from-to)766-771
Number of pages6
JournalJournal of the Chinese Medical Association
Volume81
Issue number9
DOIs
Publication statusPublished - Sep 1 2018

Fingerprint

Kidney Transplantation
Chronic Kidney Failure
Population
Stroke
Transplantation
Control Groups
National Health Programs
International Classification of Diseases
Taiwan
Dialysis
Cohort Studies
Research Design
Survival Rate
Databases
Mortality
Research

Keywords

  • End-stage renal disease (ESRD)
  • Major adverse cardia events (MACEs)
  • Renal transplantation (RT)
  • Stroke

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Renal transplantation delays major adverse cardiac events (MACEs) in patients with end-stage renal disease : A nationwide population-based study. / Liao, Hsien Tzung; Lin, Ming Chin; Tsai, Chang Youh; Hsu, Chien Yeh; Wu, Tsai Hung.

In: Journal of the Chinese Medical Association, Vol. 81, No. 9, 01.09.2018, p. 766-771.

Research output: Contribution to journalArticle

@article{9e05b7cf00fd4a1689f9fb4589c7e1dc,
title = "Renal transplantation delays major adverse cardiac events (MACEs) in patients with end-stage renal disease: A nationwide population-based study",
abstract = "Background: Whether renal transplantation (RT) influences the risk of cardiovascular events remains controversial. Methods: This nationwide population-based study investigated the risk of major adverse cardiac events (MACEs) and stroke after RT in patients with end-stage renal disease (ESRD), using data obtained from the National Health Insurance Research Database in Taiwan. A total of 164 ESRD patients who underwent RT formed the study cohort, and an age- and sex-matched control group comprised 164 patients without RT selected from 6976 ESRD patients. All patients were enrolled between January 1, 2000 and December 31, 2009. Those who developed MACEs and/or stroke during the study period were identified according to the International Classification of Diseases, Ninth Revision, Clinical Modification. A Kaplan–Meier MACEs-free curve was used to compare MACEs episodes between the study and control groups. Results: The mean age was similar between RT and non-RT patients, with most between 30 and 50 years old. In this age range, MACEs developed in 47.5{\%} of the RT group and in 52.5{\%} of the non-RT group (p = 0.0882). The survival rate among all ESRD patients was significant higher in the RT group than in non-RT group (p < 0.001). The MACEs-free, stroke-free and MACEs-or-stroke-free rates were significantly higher in the RT group than in the non-RT group (p = 0.0134, 0.035 and 0.005, respectively) as demonstrated by Kaplan–Meier curves. Conclusion: RT seemed not to reduce the risk of MACEs directly, but it could have dramatically delayed MACEs and stroke episodes in the ESRD patients. Furthermore, a lower mortality rate was observed in the ESRD patients who received RT than in those undergoing chronic dialysis. Further in-depth investigation is necessary to identify other protective factors against MACEs or stroke in ESRD.",
keywords = "End-stage renal disease (ESRD), Major adverse cardia events (MACEs), Renal transplantation (RT), Stroke",
author = "Liao, {Hsien Tzung} and Lin, {Ming Chin} and Tsai, {Chang Youh} and Hsu, {Chien Yeh} and Wu, {Tsai Hung}",
year = "2018",
month = "9",
day = "1",
doi = "10.1016/j.jcma.2018.04.003",
language = "English",
volume = "81",
pages = "766--771",
journal = "Journal of the Chinese Medical Association",
issn = "1726-4901",
publisher = "Elsevier Taiwan LLC",
number = "9",

}

TY - JOUR

T1 - Renal transplantation delays major adverse cardiac events (MACEs) in patients with end-stage renal disease

T2 - A nationwide population-based study

AU - Liao, Hsien Tzung

AU - Lin, Ming Chin

AU - Tsai, Chang Youh

AU - Hsu, Chien Yeh

AU - Wu, Tsai Hung

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Background: Whether renal transplantation (RT) influences the risk of cardiovascular events remains controversial. Methods: This nationwide population-based study investigated the risk of major adverse cardiac events (MACEs) and stroke after RT in patients with end-stage renal disease (ESRD), using data obtained from the National Health Insurance Research Database in Taiwan. A total of 164 ESRD patients who underwent RT formed the study cohort, and an age- and sex-matched control group comprised 164 patients without RT selected from 6976 ESRD patients. All patients were enrolled between January 1, 2000 and December 31, 2009. Those who developed MACEs and/or stroke during the study period were identified according to the International Classification of Diseases, Ninth Revision, Clinical Modification. A Kaplan–Meier MACEs-free curve was used to compare MACEs episodes between the study and control groups. Results: The mean age was similar between RT and non-RT patients, with most between 30 and 50 years old. In this age range, MACEs developed in 47.5% of the RT group and in 52.5% of the non-RT group (p = 0.0882). The survival rate among all ESRD patients was significant higher in the RT group than in non-RT group (p < 0.001). The MACEs-free, stroke-free and MACEs-or-stroke-free rates were significantly higher in the RT group than in the non-RT group (p = 0.0134, 0.035 and 0.005, respectively) as demonstrated by Kaplan–Meier curves. Conclusion: RT seemed not to reduce the risk of MACEs directly, but it could have dramatically delayed MACEs and stroke episodes in the ESRD patients. Furthermore, a lower mortality rate was observed in the ESRD patients who received RT than in those undergoing chronic dialysis. Further in-depth investigation is necessary to identify other protective factors against MACEs or stroke in ESRD.

AB - Background: Whether renal transplantation (RT) influences the risk of cardiovascular events remains controversial. Methods: This nationwide population-based study investigated the risk of major adverse cardiac events (MACEs) and stroke after RT in patients with end-stage renal disease (ESRD), using data obtained from the National Health Insurance Research Database in Taiwan. A total of 164 ESRD patients who underwent RT formed the study cohort, and an age- and sex-matched control group comprised 164 patients without RT selected from 6976 ESRD patients. All patients were enrolled between January 1, 2000 and December 31, 2009. Those who developed MACEs and/or stroke during the study period were identified according to the International Classification of Diseases, Ninth Revision, Clinical Modification. A Kaplan–Meier MACEs-free curve was used to compare MACEs episodes between the study and control groups. Results: The mean age was similar between RT and non-RT patients, with most between 30 and 50 years old. In this age range, MACEs developed in 47.5% of the RT group and in 52.5% of the non-RT group (p = 0.0882). The survival rate among all ESRD patients was significant higher in the RT group than in non-RT group (p < 0.001). The MACEs-free, stroke-free and MACEs-or-stroke-free rates were significantly higher in the RT group than in the non-RT group (p = 0.0134, 0.035 and 0.005, respectively) as demonstrated by Kaplan–Meier curves. Conclusion: RT seemed not to reduce the risk of MACEs directly, but it could have dramatically delayed MACEs and stroke episodes in the ESRD patients. Furthermore, a lower mortality rate was observed in the ESRD patients who received RT than in those undergoing chronic dialysis. Further in-depth investigation is necessary to identify other protective factors against MACEs or stroke in ESRD.

KW - End-stage renal disease (ESRD)

KW - Major adverse cardia events (MACEs)

KW - Renal transplantation (RT)

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=85049334704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049334704&partnerID=8YFLogxK

U2 - 10.1016/j.jcma.2018.04.003

DO - 10.1016/j.jcma.2018.04.003

M3 - Article

AN - SCOPUS:85049334704

VL - 81

SP - 766

EP - 771

JO - Journal of the Chinese Medical Association

JF - Journal of the Chinese Medical Association

SN - 1726-4901

IS - 9

ER -